Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
about
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesRole of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceHyperoside, a flavonoid compound, inhibits proliferation and stimulates osteogenic differentiation of human osteosarcoma cellsAn overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma CellsTargeting the osteosarcoma cancer stem cellmTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma.Hypoxia, stem cells and bone tumorMicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSVStrategies for isolating and enriching cancer stem cells: well begun is half doneCD133 expression associated with poor prognosis in ovarian cancer.Cancer stem cell genomics: the quest for early markers of malignant progression.Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.Molecular mechanisms of chemoresistance in osteosarcoma (Review).Orthopaedic research in italy: state of the art.Cancer stem cells in osteosarcoma: recent progress and perspective.MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.Drug treatment of cancer cell lines: a way to select for cancer stem cells?Proteomics of osteosarcoma.Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines.Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells.Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.Cancer Stem Cells and Pediatric Solid Tumors.DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells.Proliferation versus regeneration: the good, the bad and the ugly.Noncoding RNA in drug resistant sarcoma.Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model.CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.Patient-derived osteosarcoma cells are resistant to methotrexate.Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy.Establishment and Characterization of New Canine and Feline Osteosarcoma Primary Cell Lines.Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2.Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
P2860
Q26745742-B398D992-EE6F-402F-9844-9D10007E0D6FQ26865927-2889C4A4-1367-49C5-9BCC-16F1481C3AAFQ28540201-43AA0A65-B2A5-49C7-98FE-8BC9CE8E733BQ33275167-51F6A003-5F8D-4552-B706-762D2705A47EQ33709960-97C81F93-8378-4B51-AB8F-93B8A3C43A20Q33795254-1CAC086D-E437-412D-BF05-2800ADC99097Q34335524-FD4A6040-E087-4024-BA2C-6B000500954EQ35319234-6F38F350-669F-4D34-AE41-3070774DF5EBQ35549238-42B0388B-41B6-4043-8FB0-738C19D20C41Q35609245-136A75BF-BD0D-4C2D-A48D-0D2EDDCA30B1Q36030949-2C8FEA60-5C30-409F-ACCD-7F315C447351Q37061915-19B4DAFA-8D3D-422A-B519-F09E55F5CFABQ37373712-D80D86A0-9648-4183-AA68-96971ECFBB42Q37592247-24EF22CD-9965-41DD-A0BC-8AB711E2D58EQ37626756-3C221954-1663-427B-9B8F-84B32CCAFE51Q37719938-C81ED817-82CD-4672-B6D1-4BECD58D2FB3Q37888852-D9ED0968-CD05-4DDE-BCDF-4F7F99D73CBEQ37896083-257669BE-A714-4573-AD35-1402895AE652Q38086010-AF674A96-9A1B-4C28-B813-F34D54B36678Q38161343-68BCA879-0C51-4B04-AC12-9EA9DF5F346CQ38198116-54C2C5FD-1508-44AA-9F93-33BE0134A9E0Q38349935-E551E1B8-0DEB-4020-BBE1-FCE42E82C5D0Q38801373-E4DA20EF-B914-4617-815C-D3F8A9E0F23FQ38810898-29F84DE2-717F-4745-85DE-451406D617EAQ38874577-9F604D2B-4D90-4F70-935E-DC5B37F0B738Q39084225-E6A63A64-2218-4574-BF8D-4093B410672AQ39096563-6A829B6D-84C0-4B17-8DFB-3D549D6B4FBDQ39248938-5E825855-84CA-4B51-A5E0-AD76A12D191AQ39345500-49B7ABF1-BF6E-4D27-9A3E-F9356F76FA7CQ39773200-F4AF91A7-3D6C-438E-8941-2C1D9FA52ACBQ40977721-F43FA506-C119-40D4-85B0-6B861695D050Q41822073-53920A86-F1E5-47A4-B562-91E9C061D029Q41924654-5EF8289A-80FF-4B71-813D-DFF66D664374Q41945936-E037112A-F1DE-44C8-8083-1AF823E96533Q42014961-CC9B89D6-EC85-488D-AD54-1795C379FE1AQ42362093-04CB9B40-2920-4231-A924-C039E9B3537CQ42378303-CD30222A-CC48-43E0-A349-EE07CE4E891BQ46540533-6B245910-6656-455F-A5FC-E08FA2944EFEQ49193135-D21D0518-5542-48B7-BA5D-077EDA493B89Q50575582-6478A977-C933-427A-BEE5-D7BBED8A1942
P2860
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Identification and expansion o ...... rm 3-aminobenzamide treatment.
@en
Identification and expansion o ...... rm 3-aminobenzamide treatment.
@nl
type
label
Identification and expansion o ...... rm 3-aminobenzamide treatment.
@en
Identification and expansion o ...... rm 3-aminobenzamide treatment.
@nl
prefLabel
Identification and expansion o ...... rm 3-aminobenzamide treatment.
@en
Identification and expansion o ...... rm 3-aminobenzamide treatment.
@nl
P2093
P356
P1476
Identification and expansion o ...... erm 3-aminobenzamide treatment
@en
P2093
Andrea Santulli
Anna De Blasio
Concetta Messina
Giovanni Tesoriere
Giuseppe Pirozzi
Michela Giuliano
Renza Vento
Rosa Drago Ferrante
P304
P356
10.1002/JCP.21667
P577
2009-05-01T00:00:00Z